Patents matching “The United States of America as represented by the Secretary of the Department of”

US 8541221

Primate T-lymphotropic viruses

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Sep 24, 2013 · Expires Sep 19, 2033

US 8535639

Trifunctional imaging agent for monoclonal antibody tumor-targeted imaging

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 17, 2013 · Expires Sep 12, 2033

US 8524247

Rabies virus-based recombinant immunocontraceptive compositions and methods of use

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Sep 3, 2013 · Expires Aug 29, 2033

US 8518647

Method of diagnosing poor survival prognosis colon cancer using miR-16b

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Aug 27, 2013 · Expires Aug 22, 2033

US 8506947

Vaccinia virus expression vector for selective replication in a tumor cell and introduction of exogenous nucleotide sequence into a tumor cell

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 13, 2013 · Expires Aug 8, 2033

US 8501188

Method of treating inflammatory lung disease with suppressors of CpG oligonucleotides

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 6, 2013 · Expires Aug 1, 2033

US 8501182

Monoclonal antibodies that react with the capsule of Bacillus anthracis

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 6, 2013 · Expires Aug 1, 2033

US 8481055

Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 9, 2013 · Expires Jul 4, 2033

US 8481048

Methods for preparing immunogenic conjugates

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Jul 9, 2013 · Expires Jul 4, 2033

US 8476236

Treatment of skin conditions by Dickkopf1 (DKK1)

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 2, 2013 · Expires Jun 27, 2033

US 8470342

Methods of altering an immune response induced by CpG oligodeoxynucleotides

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 25, 2013 · Expires Jun 20, 2033

US 8465749

Polysaccharide-protein conjugate vaccines

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 18, 2013 · Expires Jun 13, 2033

US 8465917

Methods for determining heptocellular carcinoma subtype and detecting hepatic cancer stem cells

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Jun 18, 2013 · Expires Jun 13, 2033

US 8460660

Anti-mesothelin antibodies

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 11, 2013 · Expires Jun 6, 2033

US 8455652

Inhibitors for the soluble epoxide hydrolase

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 4, 2013 · Expires May 30, 2033

US 8454965

Method for the treatment of multiple sclerosis

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 4, 2013 · Expires May 30, 2033

US 8455437

Method to predict and prevent oxygen-induced inflammatory tissue injury

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 4, 2013 · Expires May 30, 2033

US 8440393

Pro-angiogenic genes in ovarian tumor endothelial cell isolates

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 14, 2013 · Expires May 9, 2033

US 8440411

Differential gene expression in physiological and pathological angiogenesis

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 14, 2013 · Expires May 9, 2033

US 8431134

Use of a pneumococcal P4 peptide for enhancing opsonophagocytosis in response to a pathogen

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Apr 30, 2013 · Expires Apr 25, 2033

US 8426574

Identification of astrovirus VA1 associated with gastroenteritis in humans

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Apr 23, 2013 · Expires Apr 18, 2033

US 8420099

Chimeric protein for prevention and treatment of HIV infection

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Apr 16, 2013 · Expires Apr 11, 2033

US 8420607

Anthrax carbohydrates, synthesis and uses thereof

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Apr 16, 2013 · Expires Apr 11, 2033

US 8415097

Tumor suppressor gene, p47ING3

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Apr 9, 2013 · Expires Apr 4, 2033